Utilizing hiPSC-Derived Neurons and Cardiomyocytes For Drug Screening

Video   Oct 18, 2016

 

Patient specific induced pluripotent stem cells (iPSC) complement traditional cell-based assays used in drug discovery and could aid in the development of clinically useful compounds. They allow interrogation of differentiated features of human cells not reflected by immortalized lines, and importantly they carry disease-specific traits in complex genetic backgrounds that can impact disease phenotypes. Development of technology platforms to perform compound screens of iPSC with relatively high-throughput will be essential to realize their potential for disease modeling and drug discovery. Towards this goal, we have been working to develop a standardized battery of assays against which iPSC-derived neurons can be screened for specific phenotypes. We will discuss our screening results and development of patient cell specific and hiPSC based models for testing of drugs on disease relevant cell types.

 
 
 
 

Recommended Videos

PrecisionAb™ Antibodies- Enhance Your Western Blotting Toolbox

Video

These are premium-quality antibodies extensively validated for western blotting.

WATCH NOW

Thermo Scientific™ NanoDrop™ One Microvolume UV-Vis spectrophotometer

Video

Quantify and qualify DNA, RNA, and protein samples with only 1-2 µL and have full-spectral data in seconds using the Thermo Scientific™ NanoDrop™ One Microvolume UV-Vis spectrophotometer.

WATCH NOW

MicroCal PEAQ-ITC: The gold standard for measuring binding affinities

Video

This video describes the 4 main reasons why MicroCal PEAQ-ITC is the ideal instrument for measuring binding affinities.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE